Researchers
-
Alejandro Fernández Simon
Digestive
-
Alex Blasco
Digestive
-
Alfredo Mata
Digestive
Phd -
Anna Bargallo
Digestive
Phd -
Carlos Hernández Ballesteros
Digestive
-
Celia Vasconez Peña
Digestive
-
David Barquero
Digestive
-
Eva Erice
Digestive
Phd -
Marta Martín Llahí
Digestive
Phd -
Mercè Navarro
Digestive
-
Orlando García Bosch
Digestive
Phd -
Xavier Ariza
Digestive
Phd
Contact the group
Form-
Barquero D, González V, García O, Fernández A, Blasco A, Navarro M, Bargalló A, Martín M, Erice E, Ariza X, Hernández C, Vascónez C, Martín-Baranera M, Castellví J, Mata A. 326/20
Ways to perform an endoscopic tattoo. prospective and randomized study in patients with colorectal neoplasm.
Rev Esp Enferm Dig 2020 Dec 1.
-
Cañete F, Mañosa M, Casanova MJ, González-Sueyro RC, Barrio J, Bermejo F, Nos P, Iglesias-Flores E, García-Planella E, Pérez-Calle JL, Vicente R, Vera M, Ramos L, Rivero M, De Francisco R, Montserrat A, Benítez O, Navarro P, Taxonera C, Hinojosa E, Márquez-Mosquera L, Navarro-Llavat M, Ramírez-de la Piscina P, Gomollón F, Rodríguez-Alonso L, Núñez-Alonso A, Fernández -Salazar L, Almela P, Ríos León R, De Castro L, Gisbert JP, Ricart E, Cabré E, Domènech E; ENEIDA registry by GETECCU. 175/19
Adalimumab or Infliximab for the Prevention of Early Postoperative Recurrence of Crohn's Disease: Results From the ENEIDA Registry.
Inflamm Bowel Dis. 2019;25(11):1862-1870.
-
Chaparro M, Garre A, Ricart E, Iglesias-Flores E, Taxonera C, Domènech E, Gisbert JP; ENEIDA study group. (Navarro-Llavat M) 177/19
Differences between childhood- and adulthood-onset inflammatory bowel disease: the CAROUSEL study from GETECCU.
Aliment Pharmacol Ther. 2019; 49 (4): 419-428.
-
Chaparro M, Barreiro-de Acosta M, Benítez JM, Cabriada JL, Casanova MJ, Ceballos D, Esteve M, Fernández H, Ginard D, Gomollón F, Lorente R, Nos P, Riestra S, Rivero M, Robledo P, Rodríguez C , Sicilia B, Torrella E, Garre A, García-Esquinas E, Rodríguez-Artalejo F, Gisbert JP; EpidemIBD study group of GETECCU. (Navarro-Llavat M). 174/19
EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in Spain.
Therap Adv Gastroenterol. 2019 May 21;12:1756284819847034.
-
Repici A, Coron E, Sharma P, Spada C, Di Leo M, Noble CL, Gschossmann J, Bargalló García A, Baumgart DC. 179/19
Improved high-quality colon cleansing with 1L NER1006 versus 2L polyethylene glycol plus ascorbate or oral sulfate solution.
Dig Liver Dis. 2019;51(12):1671-1677.
-
Calafat M, Mañosa M, Cañete F, Ricart E, Iglesias E, Calvo M, Rodríguez-Moranta F, Taxonera C, Nos P, Mesonero F, Martín-Arranz MD, Mínguez M, Gisbert JP, García-López S, de Francisco R, Gomollón F, Calvet X, Garcia-Planella E, Rivero M, Martínez-Cadilla J, Argüelles F, Arias L, Cimavilla M, Zabana Y, Domènech E; ENEIDA registry of GETECCU. (Garcia-Bosch O) 178/19
Increased risk of thiopurine-related adverse events in elderly patients with IBD.
Aliment Pharmacol Ther. 2019; 50 (7): 780-788.
-
Chavarría C, Casanova MJ, Chaparro M, Barreiro-de Acosta M, Ezquiaga E, Bujanda L, Rivero M, Argüelles-Arias F, Martín-Arranz MD, Martínez-Montiel MP, Valls M, Ferreiro-Iglesias R, Llaó J, Moraleja-Yudego I, Casellas F, Antolín-Melero B, Cortés X, Plaza R, Pineda JR, Navarro-Llavat M, García-López S, Robledo-Andrés P, Marín-Jiménez I, García-Sánchez V, Merino O, Algaba A, Arribas-López MR, Banales JM, Castro B, Castro-Laria L, Honrubia R, Almela P, Gisbert JP. 176/19
Prevalence and Factors Associated With Fatigue in Patients With Inflammatory Bowel Disease: A Multicentre Study
J Crohn's Colitis. 2019;13(8):996-1002.
-
Iborra M, Beltrán B, Fernández-Clotet A, Gutiérrez A, Antolín B, Huguet JM, De Francisco R, Merino O, Carpio D, García-López S, Mesonero F, Navarro P, Ferreiro-Iglesias R, Carbajo AY, Rivero M, Gisbert JP, Piñero-Pérez MC, Monfort D, Bujanda L, García-Sepulcre MF, Martín-Cardona A, Cañete F, Taxonera C, Domènech E, Nos P; GETECCU Group (Spanish Working Group on Crohn's Disease and Ulcerative Colitis). (Navarro-Llavat M). 179/19
Real-world short-term effectiveness of ustekinumab in 305 patients with Crohn's disease: results from the ENEIDA registry.
Aliment Pharmacol Ther. 2019; 50 (3): 278-288.
-
Chaparro M, Garre A, Ricart E, Iborra M, Mesonero F, Vera I, Riestra S, García-Sánchez V, Luisa De Castro M, Martin-Cardona A, Aldeguer X, Mínguez M, de-Acosta MB, Rivero M, Muñoz F, Andreu M, Bargalló A, González-Muñoza C, Pérez Calle JL, García-Sepulcre MF, Bermejo F, Huguet JM, Cabriada JL, Gutiérrez A, Mañosa M, Villoria A, Carbajo AY, Lorente R, García-López S, Piqueras M, Hinojosa E, Arajol C, Sicilia B, Conesa AM, Sainz E, Almela P, Llaó J, Roncero O, Camo P, Taxonera C, Domselaar MV, Pajares R, Legido J, Madrigal R, Lucendo AJ, Alcaín G, Domenech E, Gisbert JP; GETECCU study group. (Navarro-Llavat M) 69/18
Short and long-term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry.
Aliment Pharmacol Ther. 2018; 48 (8): 839-851.
-
Lopez-Doriga A, Valle L, Alonso MH, Aussó S, Closa A, Sanjuan X, Barquero D, Rodríguez-Moranta F, Sanz-Pamplona R, Moreno V. 18/18
Telomere length alterations in microsatellite stable colorectal cancer and association with the immune response.
Biochim Biophys Acta Mol Basis Dis. 2018;1864(9 Pt B):2992-3000.
Projects
-
Digestive
Researcher
- Year 2019
- Sant Joan Despí Moisès Broggi Hospital
Endoscopy versus surgical treatment for the treatment of pT1 colorectal cancers: Study of population-based cohorts - EpiT1.
-
DISTRICT ATTORNEY:
Dr. María Pellisé Urquiza. Clinical Hospital of Barcelona
-
TYPE E:
PI
-
- Year 2019
- Sant Joan Despí Moisès Broggi Hospital
Protocol for the detection of previously unknown liver disease in hospitalized patients with alcohol use disorder.
-
DISTRICT ATTORNEY:
Martha Martin
-
TYPE E:
PINE TREE
-
- Year 2019
- Sant Joan Despí Moisès Broggi Hospital
Effectiveness and tolerability of ustekinumab in clinical practice in patients with active Crohn's disease
-
DISTRICT ATTORNEY:
Janssen Cilag, Spain
-
TYPE E:
EPA-OD
-
- Year 2019
- Sant Joan Despí Moisès Broggi Hospital
Endoscopy versus surgical treatment for the treatment of pT1 colorectal cancers: Study of population-based cohorts - EpiT1.
-
DISTRICT ATTORNEY:
Dr. María Pellisé Urquiza. Clinical Hospital of Barcelona
-
TYPE E:
PINE TREE
-
- Year 2019
- Sant Joan Despí Moisès Broggi Hospital
Albumin for the management of hypervolemic hyponatremia in patients with decompensated cirrhosis. Concept study.
-
DISTRICT ATTORNEY:
Clinical Foundation for Biomedical Research
-
TYPE E:
RD2015
-
- Year 2019
- Sant Joan Despí Moisès Broggi Hospital
Study of the clinical and virological factors associated with virological control after withdrawal of antiviral treatment in patients with HBeAg-negative chronic hepatitis.
-
DISTRICT ATTORNEY:
Clinical Foundation for Biomedical Research
-
TYPE E:
PINE TREE
-
Digestive
Researcher
- Year 2018
- Sant Joan Despí Moisès Broggi Hospital
Multicenter, prospective study of transmural endoscopic colon resection using Over-the-Scope-Clip (OTSC),
-
DISTRICT ATTORNEY:
Girona University Hospital Doctor Josep Trueta
-
TYPE E:
PI
-
Digestive
Researcher
- Year 2018
- Sant Joan Despí Moisès Broggi Hospital
Risk of adrenal insufficiency and impact on quality of life of treatment with conventional steroids in chronic inflammatory bowel disease,
-
DISTRICT ATTORNEY:
Mercè Navarro Llavat
-
TYPE E:
PI
-
Digestive
Researcher
- Year 2018
- Sant Joan Despí Moisès Broggi Hospital
Results of vedolizumab and anti-TNFs in patients with ulcerative colitis and Crohn's disease treated in real clinical practice (EVOLVE) - IBERIA,
-
DISTRICT ATTORNEY:
Takeda Farmacéutica España SA
-
TYPE E:
EPA
-
- Year 2018
- Sant Joan Despí Moisès Broggi Hospital
Risk of adrenal insufficiency and impact on quality of life of treatment with conventional steroids in chronic inflammatory bowel disease,
-
DISTRICT ATTORNEY:
Mercè Navarro Llavat
-
TYPE E:
PINE TREE
- Digestive Endoscopy
- Inflammatory bowel disease
